Please ensure Javascript is enabled for purposes of website accessibility
Inicio > Productos > Anticuerpos > Biosimilares

Research Grade hEPO-Fc (HB152016)

Precio(USD):
Especificación:
  • 100ug
  • 1mg
  • 5mg
  • 10mg
  • 25mg
  • 50mg
  • 100mg
Número:
Contáctenos
  • Vista general

  • Imágenes

  • Referencias

  • Datasheet

  • SDS

Vista general
Número de catálogoHB152016
Descripción
Anti-Human EPOR (rhEPO-Fc) (HB152016) is a research-grade recombinant antibody targeting EPOR. Produced in mammalian cells with native-like glycosylation.
Highlights
  • ●Research Grade — For PK/PD studies, assay development, and ADA research.
  • ●Native Glycosylation — Mammalian expression ensures native-like patterns.
Reactividad de especiesHuman
AplicacionesFunctional assay
Especie huéspedHuman
Sistema de expresión Mammalian cells
Especies Homo sapiens (Human)
Objetivo EPOR, Erythropoietin receptor, EPO-R
Nivel de endotoxinas < 10 EU/mg
Pureza >95% purity as determined by SDS-PAGE.
Purificación Protein A/G purified from cell culture supernatant.
Número de acceso P01588
Forma Liquid
Buffer de almacenamiento 0.01M PBS pH 7.4

Consulte la información específica del buffer en la copia impresa del datasheet o en el COA específico del lote.

Estabilidad y almacenamiento Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Fondo

Erythropoietin receptor (EPOR) is a ~55 kDa protein. Receptor for erythropoietin, which mediates erythropoietin-induced erythroblast proliferation and differentiation. Upon EPO stimulation, EPOR dimerizes triggering the JAK2/STAT5 signaling cascade. In some cell types, can also activate STAT1 and STAT3. May also activate the LYN tyrosine kinase.

_x005F_x005F_x000D_ _x005F_x005F_x000D_
1. Zhan, H. et al. (1999) Protein engineering 12, 505-13. PMID: 10388848
_x005F_x005F_x000D_ _x005F_x005F_x000D_
2. Winkelmann, JC. et al. (1990) Blood 76, 24-30. PMID: 2163695
_x005F_x005F_x000D_ _x005F_x005F_x000D_
3. Jones, SS. et al. (1990) Blood 76, 31-5. PMID: 2163696
_x005F_x005F_x000D_ _x005F_x005F_x000D_
4. Middleton, SA. et al. (1996) The Journal of biological chemistry 271, 14045-54. PMID: 8662939
_x005F_x005F_x000D_ _x005F_x005F_x000D_
5. Syed, RS. et al. (1998) Nature 395, 511-6. PMID: 9774108
_x005F_x005F_x000D_ _x005F_x005F_x000D_
6. Kirito, K. et al. (2002) Blood 99, 102-10. PMID: 11756159
_x005F_x005F_x000D_
Nota For research use only. Not suitable for clinical or therapeutic use.
Imágenes
Referencias
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
Recomendación

Contáctenos para cotizaciones personalizadas, solicitudes en masa y cualquier otro problema.

Correo: [email protected]

Lista de distribuidores